What Maela does

Maela is a French digital health company that operates a certified medical telemonitoring platform connecting healthcare establishments with their patients across France, Belgium, and Canada. The company is operated by MN SANTE HOLDING, a private limited company registered in Paris (RCS 921 378 717 00018) and a subsidiary of La Poste Group, the French postal and logistics conglomerate. Maela serves hospitals, clinics, and medico-social establishments on a B2B basis, providing remote patient monitoring for use cases including hospital preparation, post-discharge follow-up, and chronic disease management. Its headquarters are registered at 9 rue du Colonel Pierre Avia, 75015 Paris, with operational offices in Lyon (56 rue Saint Jean de Dieu, 69007 Lyon) and a registered entity address in Saint-Didier-au-Mont-d'Or.

The platform is a web and mobile medical telemonitoring solution built as a certified medical device, hosted exclusively on OVH infrastructure under HDS (Hébergeur certifié données de santé) certification, with health data stored in France. It is composed of Maela Pro for healthcare professionals (dashboards, configurable protocols, real-time alerts, with authentication via Pro Santé Connect), Maela Patient for patients (to-do lists, secure messaging, educational content), and specialized modules including Maela Ambu (SMS-based ambulatory monitoring), Hor@ce (multi-pathology remote monitoring), Digicope (prevention campaigns), and a Canadian variant with localized data hosting. A 24/7 nursing plateau provides continuous patient monitoring, vital sign surveillance, and proactive outreach. The platform supports GDPR compliance and French health data regulations.

Revenue is generated through B2B enterprise subscription/licensing contracts with healthcare establishments, with pricing negotiated on a per-establishment basis under multi-year contracts. Patients access the service free of charge. The company distributes through direct enterprise sales to healthcare facility management, institutional procurement channels (CAIH, Upag), and benefits from corporate affiliation with La Poste Group. Capital social is stated at €37,466 and no venture capital funding rounds are disclosed. Leadership includes CEO Hubert Viot, co-founders Benoit Gignoux and Vincent Frering (both digestive surgeons), and Julien Vallas as Director of Publication. The company operates with 11–50 employees and runs a multi-language website supporting ten languages.

Name

Maela

Legal name

MN SANTE HOLDING

Website

https://maela.fr

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Maela is a French digital health company operating a certified medical telemonitoring platform for healthcare establishments across France, Belgium, and Canada, enabling remote patient monitoring, post-discharge follow-up, and chronic disease management.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring Software

NAICS

Offices of Physicians (6211)

SIC

Services-Health Services (8000), Services-Home Health Care Services (8082)

akta.pro primary industry

Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH)

akta.pro secondary industries

Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Healthcare On‑Demand Platforms (Telehealth, Home Care, Nursing) (BPAMAHAH)

Keywords

• Remote patient monitoring
• Medical telemonitoring platform
• Digital health software
• Healthcare telemonitoring
• E-health services

Headquarters

HQ city

Saint-didier-au-mont-d'or

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. B2B subscription / licensing to healthcare establishments: Maela generates revenue by licensing its telemonitoring platform to healthcare establishments (hospitals, clinics, and healthcare facilities). The healthcare institution pays Maela for access to the platform and associated services. Patients use the platform free of charge. The CGU explicitly states: 'L'accès et l'utilisation de l'Application sont gratuits pour les Utilisateurs, le prix étant acquitté par l'Etablissement de santé auprès de la Société.' The pricing is quote-based and negotiated with each healthcare establishment.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Maela sells a certified medical-device telemonitoring platform to healthcare establishments, enabling them to define patient follow-up protocols, collect patient-reported data and vital signs, receive real-time alerts on at-risk situations, and communicate securely with patients. The platform is offered under multi-year subscription contracts to hospitals, clinics, and medico-social facilities across France, Belgium, and Canada, while a 24/7 nursing plateau provides supplementary monitoring services. Patients and clinicians access the platform free of charge through web and mobile applications.

Product overview

Maela is a connected medical remote monitoring platform designed for healthcare establishments and their medical teams. The portfolio consists of a unified platform (Maela) with patient-facing (Maela Patient) and professional-facing (Maela Pro) applications, supplemented by specialized modules including Maela Ambu for SMS-based monitoring, Digicope for prevention campaigns, and Hor@ce for multi-pathology tracking. Maela Patient – Canada serves the Canadian market with localized data hosting. The platform enables healthcare establishments to define follow-up protocols, monitor patient-reported data and vital signs in real-time, detect at-risk situations, and facilitate secure communication, all while maintaining compliance with French and European health data regulations.

Differentiator

Problem solved

Functional benefit

Brands

• Maela Pro: Digital solution for improving patient follow-up for healthcare professionals.
• Maela Patient
• Maela Ambu
• Maela Patient – Canada
• Digicope
• Hor@ce

Products and services

• Maela Connected medical remote monitoring platform enabling healthcare establishments to prepare patient hospitalization, monitor patients at home, and facilitate secure communication between patients and medical teams through customizable care protocols. Sold to hospitals, clinics, and medico-social establishments as a B2B subscription.
• Maela Pro Digital solution for healthcare professionals enabling improved patient follow-up through configurable protocols, real-time alerts, dashboard monitoring of patient-reported data and vital signs, and secure care coordination. Authentication via Pro Santé Connect.
• Maela Patient Patient-facing digital application providing to-do lists for hospital preparation, overview of key care journey elements, secure messaging with medical teams, and a library of medically validated educational content. Accessible on mobile, tablet, and desktop.
• Maela Patient – Canada Digital solution for improving patient follow-up in Canadian territory, adapted to local healthcare system requirements and data residency regulations with Canadian hosting.
• Maela Ambu Digital solution enabling patient follow-up via SMS, designed for ambulatory care scenarios where lightweight communication channels are preferred over full mobile application deployment.
• Digicope Digital solution for deploying prevention campaigns, enabling healthcare establishments to reach patient populations with targeted health messaging and campaign management capabilities.
• Hor@ce Multi-pathology remote monitoring solution enabling simultaneous tracking of patients with multiple conditions through a unified platform, supporting complex care pathways across different disease states.

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered minor and core.

• CAIHminorGTM or Marketing PartnerMaela is referenced by CAIH (a French healthcare IT purchasing group), indicating that it is listed as an approved or recommended solution within their vendor catalog for healthcare establishments seeking telemonitoring solutions.
• UpagminorGTM or Marketing PartnerMaela is referenced by Upag, a healthcare advisory and purchasing group, indicating its inclusion in Upag's vendor ecosystem for healthcare IT procurement in France.
• La Poste groupcoreOthersMN SANTE HOLDING (the legal entity behind Maela) is a subsidiary of La Poste group. La Poste has designated a Group DPO with the CNIL. This is a corporate parent-subsidiary relationship, not a commercial partnership.
• OVHcoreTechnology or IntegrationOVH is the certified health data host (Hébergeur certifié données de santé, HDS) for Maela's platform. OVH holds certification under the HDS version 1.1 standard (June 2018), delivered by the Laboratoire national de métrologie et d'essais on 28 August 2018. All health data is hosted exclusively in France on OVH infrastructure.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Nouveal e-Santé: French digital health vendor offering telemonitoring and care-pathway platforms (including Covid-Surv and Digistorm) to hospitals and medico-social establishments — directly competing with Maela in French RPM procurement.
• Lifen: French health-data platform providing secure document exchange, e-prescription, and increasingly telemonitoring features to hospitals and physicians — overlapping with Maela in provider-facing French digital health workflows.
• Implicity: French remote cardiac monitoring platform used by hospitals and cardiology practices to monitor implanted devices — directly comparable as a condition-specific RPM platform with a B2B hospital go-to-market model.

Broad incumbents

• Withings Health Solutions: French connected-health device maker that has expanded into provider RPM solutions — broader device-and-software portfolio that competes with Maela in hospital remote-monitoring deployments.
• Doctolib: Dominant French health platform for appointment booking, teleconsultation, and increasingly care coordination — a broad incumbent whose expanding scope overlaps with Maela's provider-facing telemonitoring value proposition.

Emerging players

• H4D: French telemedicine solutions provider offering connected consultation booths and remote-consultation software — adjacent in the French provider-telehealth space but focused on in-person remote consultation rather than ongoing monitoring.
• Observia: French patient-engagement and health-data platform supporting pharma and provider RPM programs — comparable in B2B telemonitoring-style deployments to pharmaceutical and clinical customers.
• BioSerenity: French connected-health company specializing in remote electrophysiology monitoring (epilepsy, sleep) — comparable as a French RPM specialist selling to hospital neurology/cardiology departments.
• Voluntis: French digital therapeutics company developing software-based patient monitoring and self-management tools — comparable as a regulated French health-software provider serving chronic-condition pathways.

Others

• Almaviva Santé: Major French private hospital group that has deployed telemonitoring programs with Maela and other vendors — relevant as a representative customer/buyer ecosystem rather than a software peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/maela
• Xx.com/maela_medical
• Facebookfacebook.com/Maela-SAS-

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maela